Cilag v. Scitech: Surgical Stapler Patent Appeal Dismissed in São Paulo
Cilag GmbH International pursued an urgent injunctive relief appeal against Brazilian medical device maker Scitech Produtos Médicos over alleged infringement of BRPI0807365B1, covering electric surgical stapler technology. The Court of Justice of São Paulo dismissed the appeal, finding insufficient technical basis to grant emergency relief ahead of expert opinion at the originating court.
Urgent relief denied as São Paulo court awaits technical expert opinion
Cilag GmbH International, a Johnson & Johnson subsidiary and holder of Brazilian patent BRPI0807365B1 relating to electric surgical stapler technology, initiated an infringement action against Scitech Produtos Médicos S.A. before São Paulo courts. Cilag sought urgent relief — effectively a preliminary injunction — to restrict Scitech’s allegedly infringing activity while the substantive case was heard. The matter reached the Court of Justice of São Paulo on appeal of the lower court’s denial of that urgent measure.
The appellate court dismissed the appeal, affirming the first-instance rejection of urgent relief. The court reasoned that, at the current procedural stage, there was insufficient ‘technical ballast’ — meaning the evidentiary record lacked the technical foundation required to establish, with the necessary conviction, that a patent violation had in fact occurred. Critically, the court noted that an expert opinion is still awaited at the originating court, meaning the merits of the infringement claim remain unresolved.
The dismissal is procedural rather than substantive — it does not adjudicate whether Scitech infringes BRPI0807365B1, only that emergency relief was premature given the evidentiary posture. The underlying infringement action appears to remain active at first instance, pending the expert technical report. What drove the outcome was the Brazilian civil procedure requirement that urgent relief demands a high threshold of probability of the claimed right — a threshold the court found unmet without expert evidence in hand.
Filing to Appeal Dismissed in 0 days
Case closed June 2024; underlying infringement proceedings ongoing at first instance
Appeal dismissed: what the São Paulo ruling means for both parties
Procedural dismissal — no merits adjudication on infringement
The Court of Justice of São Paulo dismissed the appeal against denial of urgent relief. Under Brazilian civil procedure, urgent relief (tutela de urgência) requires demonstrating probability of the claimed right and risk of irreparable harm. Without a completed expert technical opinion, the court found the probability threshold unmet. This is a procedural gate, not a finding that infringement does or does not exist — the substantive claim survives at first instance.
No merits ruling issuedCilag denied injunctive leverage — but case continues below
Cilag GmbH International loses the ability to enforce urgent injunctive relief against Scitech at this stage. Without an interim injunction, Scitech may continue its commercial activities in electric surgical stapler products during the pendency of expert proceedings. Cilag’s strongest remaining lever is the forthcoming expert opinion — a favourable technical report could revive prospects for urgent relief or support a merits ruling at first instance.
Injunction denied — underlying case activeScitech retains operational freedom pending expert report
Scitech Produtos Médicos S.A. avoids an interim injunction that could have disrupted its electric surgical stapler business. The dismissal is commercially significant: injunctions in medical device patent disputes can be market-disrupting even before a final merits ruling. However, Scitech faces ongoing litigation risk — the infringement action remains live, and an adverse expert opinion could shift the balance. Scitech will likely contest the expert’s scope and methodology at first instance.
Operational continuity preserved for nowExpert opinion now the pivotal event in this dispute
For the Brazilian medical device sector, this case illustrates that patent holders seeking emergency relief in technical infringement disputes face a high evidentiary bar without prior expert analysis. Competitors and distributors in the electric surgical stapler market should monitor the outcome of the court-appointed expert opinion, which will be determinative for both urgent relief reconsideration and the substantive infringement claim against BRPI0807365B1.
Expert report now case-determinativeFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Cilag GMBH International | Company | Search in Eureka ↗ |
| Defendant | SCITECH PRODUTOS MÉDICOS S.A. | Individual | Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Court of Justice of Sao PauloSearch in Eureka ↗ |
Official order — verbatim text
The court’s dismissal language — ‘not enough technical ballast’ and ‘expert opinion is awaited at the origin’ — signals a strictly procedural disposition. The appellate panel declined to evaluate the merits of the infringement claim, anchoring the rejection solely on the evidentiary incompleteness of the record at this stage. For Cilag, the ruling preserves the right to seek urgent relief again once the expert report is available. For Scitech, the operative risk is that the same court may revisit injunctive relief if the expert opinion supports infringement — making the technical report the pivotal document in this dispute.
BRPI0807365B1 — Electric Surgical Stapler Technology
BRPI0807365B1 is a granted Brazilian patent — the ‘B1’ designation indicates a granted patent with examined and published claims — originating from PCT application filing circa 2007–2008. The patent covers electric surgical stapler technology, a category of powered endoscopic and open surgical instruments used to simultaneously cut and staple tissue during procedures such as bowel resections and lung surgery. This is a commercially high-value technology segment dominated by a small number of global medtech incumbents.
Cilag GmbH International, as a Johnson & Johnson entity, holds a substantial surgical instrument patent portfolio. BRPI0807365B1 represents J&J’s staking of IP territory in the Brazilian market for powered surgical staplers — a segment where local and regional manufacturers such as Scitech compete against global brands. The patent’s enforceability in Brazil, and specifically the scope of its claims as construed by a Brazilian court-appointed expert, will have direct implications for any competitor developing or distributing electric surgical staplers in the country.
Should you run an FTO analysis against BRPI0807365B1?
Any company developing, importing, or distributing electric surgical staplers in Brazil should treat BRPI0807365B1 as an active enforcement risk. The Cilag v. Scitech litigation confirms that Cilag is actively asserting this patent before Brazilian courts. Medical device manufacturers, OEM suppliers, and distributors whose products touch powered stapling or fastening mechanisms — including endoscopic and open surgery configurations — should conduct a formal freedom-to-operate assessment against the granted Brazilian claims before entering or expanding in the Brazilian market.
PatSnap Eureka’s FTO Search Agent can map the specific claim limitations of BRPI0807365B1 against your product’s technical specifications, flagging overlap risks and identifying design-around opportunities. Eureka also enables real-time monitoring of related Cilag and J&J surgical stapler filings across LatAm jurisdictions, so your IP team receives early warning of new patent grants or enforcement actions that could affect your commercial roadmap in Brazil and neighbouring markets.
Run a freedom-to-operate analysis on BRPI0807365B1 to assess your product’s exposure
Run FTO in Eureka →Similar surgical device patent infringement cases in Brazilian courts
Explore comparable electric surgical stapler and powered medical device patent infringement actions heard before Brazilian state and federal courts.
What this case signals for the surgical device IP landscape in Brazil
The São Paulo appellate dismissal highlights the procedural realities of enforcing MedTech patents in Brazil before expert evidence is secured.
Brazil’s urgent relief bar is high without expert technical evidence in hand
Patent holders seeking preliminary injunctions in Brazilian courts over technically complex devices — such as electric surgical staplers — should anticipate that courts will await expert opinions before granting emergency relief. Building a pre-litigation technical record, including independent expert analysis, significantly improves prospects for urgent measures.
Dismissal without prejudice to merits keeps litigation risk alive for Scitech
The appeal dismissal resolves only the procedural relief question — it does not insulate Scitech from the underlying infringement claim. Companies facing similar patent actions in Brazil should treat a denied injunction motion as a temporary reprieve, not a cleared threat. The expert report phase will be the critical battleground.
Cilag v SCITECH — key questions answered
The court dismissed Cilag GmbH International’s appeal against the lower court’s refusal of urgent relief. It found insufficient technical evidence — specifically, no completed expert opinion — to support the required probability of a patent violation under Brazilian civil procedure. The underlying infringement action on BRPI0807365B1 was not resolved and continues at first instance.
No. The dismissal is purely procedural and does not constitute a finding on the merits of the infringement claim. The court explicitly stated the expert opinion is still awaited at the originating court. A court-appointed technical expert will assess whether Scitech’s electric surgical stapler products fall within the scope of BRPI0807365B1’s claims — that analysis remains pending.
BRPI0807365B1 is a granted Brazilian patent held by Cilag GmbH International, a Johnson & Johnson subsidiary. It covers electric surgical stapler technology — powered devices used to simultaneously cut and staple tissue in surgical procedures. The ‘B1’ designation confirms it is a granted, examined patent with enforceable claims in Brazil.
Under Brazilian civil procedure, urgent relief (tutela de urgência) requires the applicant to demonstrate a probability of the right being claimed and a risk of irreparable harm. The court found that, without a completed expert technical opinion on the alleged infringement, the evidentiary record lacked the ‘technical ballast’ needed to establish sufficient probability of a patent violation — making grant of emergency relief premature at this procedural stage.
The case continues at the originating first-instance court in São Paulo, where a court-appointed expert is expected to deliver a technical opinion on whether Scitech’s products infringe BRPI0807365B1. That report will be central to both any renewed urgent relief application and the ultimate merits decision. Patent stakeholders should monitor the expert opinion filing and any subsequent appeal to the Court of Justice of São Paulo.
PatSnap Eureka searches patents and litigation data to answer instantly.